|
|
|
Insider
Information: |
Greenleaf Peter |
Relationship: |
Chief Executive Office... |
City: |
Gaithersburg |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
1,634,614 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$8,465,677 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
1,634,614 |
|
|
Total
Value |
$8,465,677 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
3
|
Stock
price went up :
|
1
|
1
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
Percentage
Gain/Loss : |
48.4%
|
-63.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Sucampo Pharmaceuticals, Inc. |
SCMP |
Chief Executive Officer |
2018-02-13 |
0 |
2015-12-31 |
0 |
Premium* |
|
Avalo Therapeutics, Inc |
AVTX |
Director |
2019-05-24 |
112,500 |
2018-03-27 |
0 |
Premium* |
|
Biodelivery Sciences Internation... |
BDSI |
Director |
2022-03-22 |
0 |
2018-08-14 |
0 |
Premium* |
|
Antares Pharma Inc |
ATRS |
Director |
2022-05-24 |
0 |
2019-06-13 |
0 |
Premium* |
|
Aurinia Pharmaceuticals Inc |
AUPH |
Chief Executive Office... |
2024-03-06 |
1,522,114 |
2021-05-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BDSI |
Biodelivery Sciences Inte... |
Director |
|
2018-08-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,644 |
3,644 |
0 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2019-05-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(300,000) |
112,500 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2019-06-13 |
4 |
A |
$2.92 |
$70,001 |
D/D |
23,973 |
23,973 |
0 |
- |
|
BDSI |
Biodelivery Sciences Inte... |
Director |
|
2019-08-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,144 |
24,788 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2020-06-11 |
4 |
A |
$2.73 |
$82,501 |
D/D |
30,220 |
54,193 |
0 |
- |
|
BDSI |
Biodelivery Sciences Inte... |
Director |
|
2020-08-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,000 |
59,788 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2021-06-10 |
4 |
A |
$4.42 |
$112,498 |
D/D |
25,452 |
79,645 |
0 |
- |
|
BDSI |
Biodelivery Sciences Inte... |
Director |
|
2021-08-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,000 |
94,788 |
0 |
- |
|
BDSI |
Biodelivery Sciences Inte... |
Director |
|
2022-01-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,246 |
105,034 |
0 |
- |
|
BDSI |
Biodelivery Sciences Inte... |
Director |
|
2022-03-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(105,034) |
0 |
0 |
- |
|
ATRS |
Antares Pharma Inc |
Director |
|
2022-05-24 |
4 |
D |
$5.60 |
$446,012 |
D/D |
(79,645) |
0 |
0 |
- |
|
36 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|